CLINICAL_TRIALS ClinicalTrials.gov record update

An Open Label Phase 1b Study to Characterise the Pharmacokinetic/Pharmacodynamic Relationship and Safety of MMV367 in Healthy Adult Participants Experimentally Infected With Blood Stage Plasmodium Falciparum

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05979207
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:51.028034+00:00
Published At: 2025-12-10T00:00:00+00:00
Record Updated At: 2025-12-10
Results Posted At: 2025-12-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Infections", "Vector Borne Diseases", "Systemic Inflammatory Response Syndrome", "Inflammation", "Pathologic Processes", "Malaria", "Malaria,Falciparum", "Parasitemia", "Parasitic Diseases", "Protozoan Infections", "Antimalarials", "Anti-Infective Agents"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-12-10"
protocolSection.identificationModule.nctId: "NCT05979207"
protocolSection.identificationModule.officialTitle: "An Open Label Phase 1b Study to Characterise the Pharmacokinetic/Pharmacodynamic Relationship and Safety of MMV367 in Healthy Adult Participants Experimentally Infected With Blood Stage Plasmodium Falciparum"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-12-10"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.